These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6432779)

  • 1. Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.
    Rall SC; Weisgraber KH; Mahley RW; Ogawa Y; Fielding CJ; Utermann G; Haas J; Steinmetz A; Menzel HJ; Assmann G
    J Biol Chem; 1984 Aug; 259(16):10063-70. PubMed ID: 6432779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type.
    Menzel HJ; Assmann G; Rall SC; Weisgraber KH; Mahley RW
    J Biol Chem; 1984 Mar; 259(5):3070-6. PubMed ID: 6421816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.
    Utermann G; Haas J; Steinmetz A; Paetzold R; Rall SC; Weisgraber KH; Mahley RW
    Eur J Biochem; 1984 Oct; 144(2):325-31. PubMed ID: 6489332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
    Marcil M; Boucher B; Krimbou L; Solymoss BC; Davignon J; Frohlich J; Genest J
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1015-24. PubMed ID: 7627690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant.
    Takada Y; Sasaki J; Ogata S; Nakanishi T; Ikehara Y; Arakawa K
    Biochim Biophys Acta; 1990 Apr; 1043(2):169-76. PubMed ID: 2107878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional properties of natural and chemical variants of apolipoprotein A-I.
    Jonas A; von Eckardstein A; Churgay L; Mantulin WW; Assmann G
    Biochim Biophys Acta; 1993 Feb; 1166(2-3):202-10. PubMed ID: 8443238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
    Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
    J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of lecithin cholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids.
    Zorich N; Jonas A; Pownall HJ
    J Biol Chem; 1985 Jul; 260(15):8831-7. PubMed ID: 3926761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.
    Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP
    J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation.
    Emmanuel F; Steinmetz A; Rosseneu M; Brasseur R; Gosselet N; Attenot F; Cuiné S; Séguret S; Latta M; Fruchart JC
    J Biol Chem; 1994 Nov; 269(47):29883-90. PubMed ID: 7961983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
    Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
    Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cofactor requirement for the acylation and hydrolysis reactions catalyzed by purified lecithin-cholesterol acyltransferase. Effect of low density lipoproteins and apolipoprotein A-i.
    Subbaiah PV; Chen CH; Albers JJ; Bagdade JD
    Atherosclerosis; 1982 Nov; 45(2):181-90. PubMed ID: 7159494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants.
    Holvoet P; Zhao Z; Vanloo B; Vos R; Deridder E; Dhoest A; Taveirne J; Brouwers E; Demarsin E; Engelborghs Y
    Biochemistry; 1995 Oct; 34(41):13334-42. PubMed ID: 7577918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I.
    Chen CH; Albers JJ
    Eur J Biochem; 1986 Mar; 155(3):589-94. PubMed ID: 3082628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.
    von Eckardstein A; Funke H; Henke A; Altland K; Benninghoven A; Assmann G
    J Clin Invest; 1989 Dec; 84(6):1722-30. PubMed ID: 2512329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
    Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
    Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV.
    Steinmetz A; Utermann G
    J Biol Chem; 1985 Feb; 260(4):2258-64. PubMed ID: 3918999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.